Arihiro Kiyosue

Tirzepatide Once Weekly for the Treatment of Obesity

Ania M. Jastreboff, Louis J. Aronne, Nadia N. Ahmad et al. · New England Journal of Medicine · 2022 · 3.2K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes

Vanita R. Aroda, Julio Rosenstock, Yasuo Terauchi et al. · Diabetes Care · 2019 · 468 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment

Carol Wysham, Harpreet S. Bajaj, Stefano Del Prato et al. · New England Journal of Medicine · 2024 · 50 citations

Medicine, Endocrinology, Pharmacotherapy +7

Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Takashi Kadowaki, Arihiro Kiyosue, Tomotaka Shingaki et al. · The Lancet Diabetes & Endocrinology · 2025 · 34 citations

Pharmacy, Endocrinology, Pharmacotherapy +7